We are live on ! Find out more
Franklin Resources

Franklin Resources Portfolio holdings

AUM $474B Turnover 11.72%
1-Year Est. Return 32.39%
 

Franklin Resources is the parent of the Franklin Templeton fund brands, founded in 1947 by Rupert H. Johnson Sr., a Wall Street retail broker who named it after Benjamin Franklin. Rupert Sr.'s son Charles B. Johnson became president and chief executive in 1957, and the company went public in 1971. In 1992 Franklin bought Templeton, Galbraith & Hansberger, which was then owned by mutual fund pioneer Sir John Templeton, and in 2020 it bought Legg Mason. Its fund brands include Franklin for bond funds, Templeton for international funds and Mutual Series for value funds. Its funds include Templeton Growth, opened in 1954, Mutual Shares, opened in 1949, and Mutual Discovery, opened in 1992. It launched its first ETFs in 2013 and a bitcoin and ether ETF in 2025, and in August 2026 Franklin Resources renamed itself Franklin Templeton, Inc. to match its brand.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+32.39%
3 Year Est. Return
+131.72%
5 Year Est. Return
+150.79%
10 Year Est. Return
+475.04%
AUM
$197B
AUM Growth
+$3.87B
Cap. Flow
-$7.12B
Cap. Flow %
-3.61%
Top 10 Hldgs %
13.25%
Holding
1,551
New
87
Increased
449
Reduced
640
Closed
67
Avg Time Held
2.7 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$677M
2
BHI
Baker Hughes
BHI
+$625M
3
WMB icon
Williams Companies
WMB
+$425M
4
VTRS icon
Viatris
VTRS
+$403M
5
ORCL icon
Oracle
ORCL
+$378M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$958M
2
STJ
St. Jude Medical
STJ
+$715M
3
AAPL icon
Apple
AAPL
+$637M
4
MOS icon
Mosaic
MOS
+$528M
5
DE icon
Deere & Co
DE
+$493M

Sector Composition

Rank Sector Weight
1 Healthcare 17.55%
2 Financials 15.62%
3 Technology 13.5%
4 Industrials 9.43%
5 Energy 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.82T
$4.79B 2.43%
72,768,959
-14,944,627
-17% -$958M
2013 Q2
15 quarters
MDT icon
2
Medtronic
MDT
$128B
$3.11B 1.58%
38,657,194
+1,421,098
+4% +$111M
2013 Q2
15 quarters
AAPL icon
3
Apple
AAPL
$5.08T
$2.96B 1.5%
82,488,100
-19,334,720
-19% -$637M
2013 Q2
15 quarters
JPM icon
4
JPMorgan Chase
JPM
$853B
$2.64B 1.34%
30,007,142
-5,093,233
-15% -$449M
2013 Q2
15 quarters
LLY icon
5
Eli Lilly
LLY
$1.2T
$2.47B 1.25%
29,362,979
-5,373,604
-15% -$430M
2013 Q2
15 quarters
WFC icon
6
Wells Fargo
WFC
$243B
$2.33B 1.18%
41,894,199
-1,007,470
-2% -$57.2M
2013 Q2
15 quarters
RDS.A
7
DELISTED
Royal Dutch Shell Class A
RDS.A
$2.31B 1.17%
44,481,326
-651,909
-1% -$34M
2013 Q2
15 quarters
TEVA icon
8
Teva Pharmaceutical Industries
TEVA
$46.6B
$1.93B 0.98%
60,111,053
+3,475,750
+6% +$119M
2013 Q2
15 quarters
PEP icon
9
PepsiCo
PEP
$188B
$1.81B 0.92%
16,177,564
+506,412
+3% +$54.3M
2013 Q2
15 quarters
C icon
10
Citigroup
C
$194B
$1.75B 0.89%
29,326,031
-729,578
-2% -$43.2M
2013 Q2
15 quarters
ORCL icon
11
Oracle
ORCL
$357B
$1.7B 0.86%
38,013,870
+9,068,535
+31% +$378M
2013 Q2
15 quarters
DD icon
12
DuPont de Nemours
DD
$20.1B
$1.68B 0.85%
10,432,600
-838,925
-7% -$130M
2013 Q2
15 quarters
CVX icon
13
Chevron
CVX
$402B
$1.67B 0.85%
15,560,564
-1,525,081
-9% -$171M
2013 Q2
15 quarters
MRK icon
14
Merck
MRK
$329B
$1.67B 0.85%
27,477,029
-2,705,725
-9% -$164M
2013 Q2
15 quarters
GE icon
15
GE Aerospace
GE
$336B
$1.62B 0.82%
11,322,062
-1,306,915
-10% -$189M
2013 Q2
15 quarters
SYK icon
16
Stryker
SYK
$119B
$1.6B 0.81%
12,173,456
-96,738
-0.8% -$12.2M
2013 Q2
15 quarters
PFE icon
17
Pfizer
PFE
$157B
$1.57B 0.79%
48,249,574
+2,242,261
+5% +$70.7M
2013 Q2
15 quarters
AIG icon
18
AIG
AIG
$41.3B
$1.51B 0.76%
24,112,572
-117,949
-0.5% -$7.57M
2013 Q2
15 quarters
D icon
19
Dominion Energy
D
$58.3B
$1.47B 0.75%
18,982,772
-575,494
-3% -$43.5M
2013 Q2
15 quarters
RTX icon
20
RTX
RTX
$266B
$1.46B 0.74%
20,736,045
-1,706,268
-8% -$120M
2013 Q2
15 quarters
BHI
21
DELISTED
Baker Hughes
BHI
$1.43B 0.72%
23,846,468
+10,264,306
+76% +$625M
2013 Q2
15 quarters
CSCO icon
22
Cisco
CSCO
$382B
$1.41B 0.71%
41,642,868
-3,238,195
-7% -$105M
2013 Q2
15 quarters
MET icon
23
MetLife
MET
$61.6B
$1.34B 0.68%
28,375,573
+180,465
+0.6% +$8.6M
2013 Q2
15 quarters
CELG
24
DELISTED
Celgene
CELG
$1.34B 0.68%
10,730,119
+323,797
+3% +$38.7M
2013 Q2
15 quarters
KO icon
25
Coca-Cola
KO
$411B
$1.28B 0.65%
30,127,689
-48,426
-0.2% -$2.02M
2013 Q2
15 quarters

Similar funds

Franklin Resources's Q1 2017 Portfolio in Review

As of Q1 2017, Franklin Resources held 1,551 positions worth $197B, up 2% from $193B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Franklin Resources withdrew a net $7.12B in Q1 2017, closing 67 positions and reducing 640 holdings. Its most notable exit was St. Jude Medical, an estimated $715M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, Franklin Resources opened a new position in Qiagen worth $676M.

  • Franklin Resources's largest Q1 2017 buy was Qiagen: 21,971,206 shares worth $676M.
  • Franklin Resources added most to Baker Hughes in Q1 2017, an estimated $625M increase.
  • Franklin Resources's biggest Q1 2017 reduction was Microsoft, cutting an estimated $958M.
  • Franklin Resources fully exited St. Jude Medical in Q1 2017, selling an estimated $715M.
  • Franklin Resources's ten largest holdings make up 13% of its $197B portfolio in Q1 2017.
  • Franklin Resources opened 87 new positions and closed 67 in Q1 2017.
  • Franklin Resources's portfolio value rose 2% quarter-over-quarter to $197B.

Based on Franklin Resources's 13F filing for Q1 2017, filed 12 May 2017.